FPA
BIO icon

First Pacific Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Pacific Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
401,861
-5,497
-1% -$1.56M 1.46% 24
2026
Q1 		$114M Buy
407,358
+5,901
+1% +$1.7M 1.59% 21
2025
Q4 		$122M Buy
401,457
+7,043
+2% +$2.2M 1.6% 24
2025
Q3 		$111M Buy
394,414
+7,465
+2% +$2.03M 1.53% 23
2025
Q2 		$93.4M Buy
386,949
+14,394
+4% +$3.4M 1.34% 24
2025
Q1 		$90.7M Buy
372,555
+214,705
+136% +$64.6M 1.45% 22
2024
Q4 		$51.9M Sell
157,850
-27
-0% -$9.16K 0.74% 30
2024
Q3 		$52.8M Sell
157,877
-2,675
-2% -$850K 0.73% 31
2024
Q2 		$43.8M Buy
160,552
+55,813
+53% +$16.2M 0.59% 34
2024
Q1 		$36.2M Buy
104,739
+99,873
+2,052% +$32.8M 0.51% 33
2023
Q4 		$1.57M Buy
+4,866
New +$1.53M 0.02% 57
2015
Q4 		– Sell
-1,500
Closed -$201K – 112
2015
Q3 		$201K Hold
1,500
– – ﹤0.01% 127
2015
Q2 		$226K Sell
1,500
-218,700
-99% -$31.3M ﹤0.01% 108
2015
Q1 		$29.8M Sell
220,200
-5,200
-2% -$645K 0.25% 65
2014
Q4 		$27.2M Hold
225,400
– – 0.22% 66
2014
Q3 		$25.6M Hold
225,400
– – 0.21% 74
2014
Q2 		$27M Hold
225,400
– – 0.22% 76
2014
Q1 		$28.9M Sell
225,400
-2,900
-1% -$372K 0.25% 73
2013
Q4 		$28.2M Sell
228,300
-75,400
-25% -$9.19M 0.27% 70
2013
Q3 		$35.7M Sell
303,700
-600
-0.2% -$70.8K 0.37% 64
2013
Q2 		$34.1M Buy
+304,300
New +$35.7M 0.36% 66

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Pacific Advisors's BIO Position: Q2 2026 in Review

First Pacific Advisors reduced its Bio-Rad Laboratories Class A (BIO) stake by 1.3% in Q2 2026, selling an estimated $1.56M and leaving 401,861 shares worth $118M. The position accounts for 1.46% of the portfolio, ranked #24.

First Pacific Advisors first reported a position in BIO in Q2 2013 and has held it in 21 quarters since. The position peaked at $122M in Q4 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • First Pacific Advisors held 401,861 shares of Bio-Rad Laboratories Class A worth $118M as of Q2 2026.
  • First Pacific Advisors sold 5,497 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.56M.
  • Bio-Rad Laboratories Class A made up 1.46% of First Pacific Advisors's portfolio in Q2 2026, its #24 holding.
  • First Pacific Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 21 quarters since.
  • First Pacific Advisors's Bio-Rad Laboratories Class A position peaked at $122M in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on First Pacific Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.